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Eight to nine year mortality in known non-insulin dependent diabetics
and controls. Microalbuminuria is known to predict mortality in elderly,
non-insulin dependent diabetic individuals. To test whether this is also
so when studied prospectively and over a longer period, we followed
228 persons with known diabetes mellitus and an age and sex matched,
non-diabetic cohort for eight to nine years. Both cohorts were found
during a population screening in 1981—1982 of 5292 citizens aged 60 to 74
years. At ascertainment extensive clinical and biochemical examina-
tions including determination of urinary albumin were carried out. At
May 15, 1990 111 diabetic and 46 non-diabetics had died (P < 0.0001).
In the diabetic cohort the median value of urinary albumin excretion
(UAE) was 17.40 g/min. In the group with values at or above 17.40
sg/min 62 died, compared with 40 deaths in the group with values below
(P = 0.003). In the non-diabetic cohort the median UAE value was 7.52
gJmin. In the upper group 26 died, in the lower 15 (P = 0.05). Cox
regression analyses showed coefficients of regression for ln(UAE) of
0.333 (P < 0.001) for the diabetic group and 0.236 (P = 0.048) for the
non-diabetic group. In the Cox model for the diabetics, ischemic heart
disease was also of independent significance to mortality. The final
model for the non-diabetics included hypertension and sex as significant
variables. It is concluded that in a prospective study of elderly diabetics
urinary albumin excretion rate is the best prognostic factor for long-
term mortality. In non-diabetics the same association between the
levels of albumin excretion and mortality is seen, but here other factors,
such as hypertension and sex seem to concur.
Excretion of urinary albumin between 20 and 200 g/min has
been designated microalbuminuria [1], and is found strongly
prognostic of death in retrospective studies of non-insulin
dependent diabetes [2—4]. The association between albumin
excretion and the risk of death is present also when other
known risk factors such as male sex, age, obesity, ischemic
heart disease, hypertension, smoking, and elevated blood lipids
are taken into account [1, 3, 5].
Non-insulin dependent diabetes patients with microalbumin-
uria mainly die from cardiovascular diseases [4]. It has also
been found that microalbuminuria is associated with hyperten-
sion in non-insulin dependent diabetes and in non-diabetic
persons [6] and with increased cardiovascular morbidity in
non-diabetic persons [5, 7].
In the Fredericia study [8] we have followed a representative
cohort of known non-insulin dependent diabetic subjects 60 to
74 years old found during population screening, and a control
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group of non-diabetics representative for the background pop-
ulation for 7.59 to 9.28 years or to death. We compared
mortality and the relation of urinary albumin excretion (UAE)
to mortality taking other possible risk factors into account.
Methods
Design of the epidemiological study
From the first of February 1981 to the end of October 1982 all
subjects aged 60 to 74 years living in the municipality of
Fredericia, Denmark were invited to have their blood glucose
measured after overnight fasting. The participants were inter-
viewed about a possible history of diabetes. Details of the
sampling procedure and the characteristics of the non-respond-
ers have been described previously [8]. An individual was
considered to have diabetes if he or she gave a positive history
of diabetes. If the fasting blood glucose at the screening was
below 7.0 mmol/liter, confirmation of the diagnosis was ob-
tained from general practitioners and hospital records.
All screened persons were numbered consecutively. For each
diabetic individual a control subject was defined as the person
with the nearest following number, who was of the same sex
and age (within one year), and whose fasting blood glucose was
below 7.0 mmol/liter.
All persons identified as having diabetes and the control
subjects were invited to have an extensive examination.
Blood and urine sampling
This was carried out on fasting subjects not later than three
weeks after the screening.
(1.) Tests on venous blood included blood glucose, serum
creatinine, triglycerides, total cholesterol, very low density
lipoproteins (VLDL), low density lipoproteins (LDL), high
density lipoproteins (HDL), and C-peptide were performed
before and six minutes after the injection of one mg of glucagon
intravenously [9].
(2.) Urine tests were performed within one week of the blood
sampling. The patients were again fasting or had had a light
meal and had drunk at most 500 ml of water during the
preceding four hours. After voiding they drank 200 ml of water,
waited for one hour and then voided again. This second urine
specimen was frozen and later analyzed for albumin and creat-
mine. The urine was also tested for signs of urinary tract
infection.
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Table 1. Sex and age distribution (%) of diabetic and non-diabetic study population
Age
years
60—65
65—69
70—74
Total
Diabetic subjects Non-diabetic subjects
Men
26 (28.6)
29(31.9)
36 (39.5)
91
Women
34 (24.7)
47 (34.2)
56 (40.8)
137
M/F Men Women M/F
0.76
0.61
0.64
0.66
28 (31.4)
28 (31.4)
33 (37.1)
89
36 (26.9)
45 (33.6)
53 (39.6)
134
0.78
0.62
0.62
0.66
Clinical examination
The participants were asked to complete a Rose question-
naire on symptoms of angina pectoris, and they were inter-
viewed about their drug consumption and smoking habits.
Height and weight were measured without shoes and over-
coat. Blood pressure was measured on the right arm by an
electronic sphygmomanometer (Kontron 3000) after 10 minutes
of rest in the supine position. Disappearance of the Korotkoff
sound (phase V) was taken as an indication of the diastolic
blood pressure.
A 12-lead resting electrocardiogram was recorded in a sitting
subject before and after exercise. The ECGs were interpreted
according to the Minnesota code [101 by one coder, who did not
know whether the subject had diabetes or not.
A 6-lead exercise ECG was recorded every minute of a
bicycle test which was carried out in the sitting position. Men
started at 50 W, women at 25 W. The work load was increased
stepwise until exhaustion or other reasons for stopping the test
[11].
Definitions
Body mass index (BMI) was calculated as
weight(kg)/height(m2).
Hypertension was defined as a systolic blood pressure  160
mm Hg, and/or a diastolic 95 mm Hg or treatment for
hypertension.
Ischemic heart disease (IHD) was diagnosed if a person had
one or more of the following signs: (1.) angina pectoris, (2.)
previous myocardial infarction verified during hospital admis-
sion, (3.) significant changes in the resting ECG (Minnesota
code: 1.1 to 1.3, 4.1 to 4.4, 5.1 to 5.3, 7.1), (4.) ST-segment
changes >1 mm during exercise, (5.) ST-items, T-items or left
bundle branch block after exercise (Minnesota code: 11.1 to
11.5, 12.1 to 12.4, 14.1).
Urinary tract infection was defined as follows: All urine
specimens were tested for the presence of leucocytes by a
Cytur test strip [12]. If positive a clean voided specimen was
examined by microscopy. If more than three leucocytes were
seen, the urine was incubated. Infection was noted, if more than
i0 bacteria were found per ml.
Laboratory methods
Blood glucose was analyzed by a hexokinase method [131,
plasma C-peptide by radioimmunoassay [14], plasma lipopro-
teins by ultracentrifugation and electrophoresis [15]. Serum and
urine creatinine was measured by the kinetic method of Jaffe
using a Beckman Astra Analyzer (Beckman Instruments, Ful-
lerton, California, USA). Urinary albumin was determined by
radioimmunoassay [16].
Statistical methods
The following methods were used: tests, log rank tests,
and Cox regression analyses.
For the log rank tests the continuous variables (urinary
albumin excretion rate, fasting blood glucose, age, stimulated
plasma C-peptide, body mass index, VLDL, HDL, triglycer-
ides, and serum creatinine) were tested ungrouped by the exact
values. LDL, total cholesterol, and creatinine clearance could
not be transformed into a normal distribution in a simple way
and were therefore divided into groups with values below the
median and values above. The discontinuous variables (sex,
antidiabetic treatment, smoker/non-smoker, and presence/ab-
sence of ischemic heart disease, hypertension, and urinary tract
infection) were grouped into classes.
The Cox regression analyses were carried out separately on
the diabetic and the non-diabetic population. This strategy may
lead to some loss of statistical power compared to an analysis
performed on the entire population, but it was preferred here
because of the apparent interaction between some of the risk
factors and the diabetic and the non-diabetic group. Such
interactions may be included in the modelling but will produce
a more complex final model. Subjects not represented by a
complete set of observations were excluded from the regression
analyses.
Proportionality was checked by observing a constant differ-
ence (independent of time) between plots of estimates of log
(integrated hazard). Logarithmic transformation of the UAE
variables [ln(UAE)] was necessary to obtain linearity. The risk
factors found to be of prognostic value in the log rank test were
all entered into a first model, which was reduced using standard
elimination procedure.
The follow-up study
In the early months of 1990 all participants were traced
through the National Register. If a participant had died before
May 15, 1990, the date of death was recorded. The observation
period was defined as the number of days from the date of
ascertainment during the population screening in 1981 to 1982 to
the date of death or May 15, 1990.
Results
During the screening 5699 citizens aged 60 to 74 were invited,
5292 (92.9%) accepted. Of these 236 gave a history of diabetes
and 228 (96.6%) consented to further examination, as did 223
controls (94,5%). The age and sex distribution of the two study
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Table 2. Number of deaths in 211 diabetic and 216 non-diabetic
subjects, distributed according to quartiles of urinary albumin
excretion
Quartiles First Second Third Fourth
Diabetic subjects
UAE interval <7.89 7.89—17.39 17.40—77.89 77.90
g/min
No. of deaths
Observed 21 18 26 37
Expected 28.9 27.7 26.6 19.3
= 21.4;
P = 0.00009
Non-diabetic subjects
UAE interval <4.77 4.77—7.51 7.52—14.84 14.85
gIrnin
No. of deaths
Observed 7 8 8 18
Expected 10.6 9.8 11.7 8.9
= 12.0;
P = 0.0071
Log rank analyses.
groups as well as that of the corresponding total population of
the municipality is seen in Table 1.
Among the 228 diabetic subjects 111(48.7%) died, and 46
(20.6%) of the 223 controls died (x. = 39.11, P <0.0001). A
comparison by a log rank test also showed a highly significant
difference ( = 42,0, P < 0.0001).
Urinary albumin excretion rate (UAE) was determined in 211
diabetic persons. Among 104 whose excretion rates were below
the median value of 17.40 jg/min 39 died; among 107 with
values at or above the median 63 died (x2 = 8.02, P = 0.003).
The median UAE value in 216 non-diabetic persons was 7.52
g/min. Among 107 with lower values 15 died, among those
with values at or above 26 died ( = 3.64, P = 0.05).
The relationship between mortality and UAE was analyzed
by log rank tests after dividing both groups into quartiles of
UAE (Table 2). In both population samples an increase in
mortality was observed with increasing levels of UAE.
The continous and discontinous variables included in the
further analyses are listed in Tables 3 and 4. The log rank tests
showed that the following variables were significantly associ-
ated with survival in the diabetic group: ln(UAE), ischemic
heart disease, sex, serum creatinine, hypertension, HDL,
VLDL, and triglycerides.
Cox regression analyses were done for the diabetic and the
non-diabetic groups separately (Table 5). ln(UAE) was the only
risk factor of prognostic value in both groups. The coefficient
for ln(UAE) was higher in the diabetic than in the non-diabetic
group. In the diabetic group the presence of ischemic heart
disease was also of prognostic value. In the non-diabetic group
hypertension and male sex were also important prognostic
factors.
Discussion
We followed 228 diabetic and 223 non-diabetic controls aged
60 to 74 years for 7.59 to 9.28 years. As expected, many more
diabetic patients (111) than controls (46) died. Further analysis
revealed that almost twice as many diabetic persons with an
UAE at or above the median value of 17.40 g/min died as
persons with lower UAE values.
Table 3. Characteristics of the continuous variables studied in
diabetic and non-diabetic subjects
Diabetic subjects Non-diabetic subjects
Total no. Total no.
exam. P exam. P
value of value of
Median log rank Median log rank
quartiles test quartiles test
Age 68.2 228 68.1 223
years 64.1—71.6 NS 63.6—71.3 0.057
Duration of diabetes 5.4 228 —
years 2.7—10.4 NS
Fasting BG 7.55 228 4.55 223
rnrnol/liter 5.53—10.27 NS 4.22—4.91 0.052
Stimulated C-peptide 1.30 228 1.38 223
rnrno!/l 0.95—1.75 NS 0.98—1.77 NS
UAEtg/min 17.40
7.89—77.90
211
<0.0001
7.52
4.77—14.85
216
0.006
BMI kg/rn 26.98
24.23—30.02
220
NS
24.90
22.44—27.68
223
NS
Triglycerides g/liter 1.49
1.00—2.40
228
0.047
1.21
0.88—1.65
223
NS
Total cholesterol 6.03 228 6.57 223
glliter 5.38—7.07 NS 6.03—7.40 NS
VLDL g/liter 1.80
1.20—2.95
226
0.047
1.40
1.00—1.90
223
NS
LDL gluier 4.58
3.79—5.46
226
NS
4.91
4.29—5.67
223
NS
HDL gluier 3.20
2.60—4.10
226
0.018
3.80
3.10—4.90
223
0.039
Serum creatinine 92.5 228 97.1 223
srnoll!iter 79.3—105.8 0.010 82.3—101.8 0.001
Creatinine clearance 76.40 205 86.75 216
mllrninll.73 rn2 58.20—94.30 NS 68.95—96.40 NS
In the log rank tests on mortality the populations were divided at the
median values. Abbreviations are: UAE, urinary albumin excretion
rate; VLDL, very low density lipoproteins; LDL, low density lipopro-
teins; HDL, high density lipoproteins.
The effect of proteinuria in non-insulin dependent diabetes
mellitus was assessed in Pima Indians [171. The mortality in
individuals with proteinuria l g/day was 3.5 times that of
individuals without proteinuria.
In our study, the log rank test utilizing information on
individual survival times suggests that the association between
the level of excretion of urinary albumin and the risk of death
may even extend below the value of 20 sg/min that has been
proposed as clinically important [1]. We have now found that
this is also so when elderly probands are followed in a prospec-
tive study with an observation period of eight to nine years.
In Framingham a cohort of non-diabetics aged 50 to 62 years
at entry into the study was followed for 16 years. Proteinuria
(20 mg/100 ml) increased the mortality rate threefold [18].
In our non-diabetic persons microalbuminuria was a strong
predictor of death as was suggested in the study by Yudkin,
Forrest and Jackson [7]. Six out of nine deaths in 149 non-
diabetic persons during an average observation time of 3.6
years occurred in 24 subjects with an initial UAE above 20
sgImin. The population was younger than ours (60 vs. 68
years). We have previously published results on five to six
years of follow-up in the non-diabetics [19]. Urinary albumin
excretion rate had the same predictive effect for mortality as for
known diabetics. Our results now suggest that for a longer
observation period in this elderly non-diabetic population, other
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Table 4. Charac
d
teristics of the discontinuous variables studied in
iabetic and non-diabetic subjects
Diabetic subjects Non-diabetic subjects
Total no. Total no.
exam. P exam. P
value of value of
log rank log rank
test on test on
No. (%) mortality No. (%) mortality
Sex 228 223
Male 91(39.9) 0.005 89 (39.9) 0.004
Female 137 (60.1) 134 (60.1)
Treatment 228 — —
Diet alone 66 (30.0) NS
OHA 101 (44.3)
Insulin 52 (22.8)
No treatment 9 (3.9)
No. with IHD 133 (58.3) 228 87 (38.2) 223
0.004 0.035
No. with 118 (51.2) 228 71(31.8) 223
hypertension 0.011 0.0001
No. with urinary 46 (20.2) 228 16 (7.2) 223
infection NS NS
No. of smokers 82 (36.0) 228 108 (48.4) 223
NS NS
In the log rank tests on mortality the populations were divided
according to absence or presence of the characteristics (IHD, hyper-
tension, and smoking) or according to groups as stated (e.g. age and
treatment). Abbreviations are: IHD, ischeniic heart disease; OHA, oral
hypoglycemic agents.
factors such as presence of hypertension and male sex may also
have a strong influence on mortality.
Microalbuminuria is linked to vascular disease. In non-insulin
dependent diabetes mellitus microalbuminuria is associated
with coronary heart disease [5]. The causes of death are mainly
cardiovascular [43, symptomatic nephropathy being rare. In a
previous publication [6] we discussed the association between
microalbuminuria and hypertension in the same population as
described in the present paper, and found that a slight associ-
ation was present both in the diabetic and the non-diabetic
subjects. Yudkin et al [7] reported on an association between
vascular disease and microalbuminuria in non-diabetic persons.
They found that UAE above 20 tg/min strongly predicted the
presence of ischemic heart disease and peripheral vascular
diseases.
A great number of other risk factors apart from microalbu-
minuria are supposed to influence morbidity and mortality in
diabetic and non-diabetic individuals. The presumed risk fac-
tors investigated in our study are listed in Tables 3 and 4.
Total cholesterol and HDL were included, as they have been
shown to be related to cardiovascular morbidity in the Framing-
ham study of people aged 49 years and older [20]. LDL is
positively associated with coronary artery disease in non-
diabetic individuals [21]. Triglycerides and VLDL may play a
role for the development of vascular diseases as discussed by
PyOrälä, Laakso and Uusitupa [22]. Plasma C-peptide was
included as it has been suggested that hyperinsulinemia is
associated with high prevalence of cardiovascular diseases
[23—25].
Apart from ln(UAE) the variables improving the Cox models
were different in the diabetic and the non-diabetic groups. In the
Table 5. Regression parameters of the final Cox regression analyses
models
Risk factor
Regression
coefficient
Standard
error
P
value
Diabetic subjects (209)
ln(UAE) 0.333 0.063 0.001
IHD
Present 0.625 0.221 0.004
Absent 0
Non-diabetic subjects
(216)
Hypertension
Present 1.024 0.326 0.002
Absent 0
Sex
Male 0.091 0.319 0.004
Female 0
ln(UAE) 0.236 0.110 0.048
Age 0.061 0.036 0.088
Abbreviations are: UAE, urinary albumin excretion rate; HDL, high
density lipoprotein; IHD, ischemic heart disease.
diabetic group ischemic heart disease was important. In another
Danish study of the association between microalbuminuria and
mortality in NIDDM patients [4], a Cox regression analysis
showed that UAE, age, diabetes duration, and serum creatinine
were of significance. The difference between the findings in that
study and ours may be due to differences in ascertainment
(out-patient vs. diabetic patients found during a population
screening and retrospective vs. prospective collected data), age
range (50 to 75 vs. 60 to 74), and finally the other risk factors
entered into the analysis.
The level of UAE may reflect the vascular status of an
individual, diabetic or non-diabetic [26]. A link has been pro-
posed in insulin dependent diabetes, as the increased perme-
ability in the glomeruli may also be demonstrated in other
vessels [27].
In the single factor analysis we found that HDL, VLDL,
triglycerides, and IHD were of significance to mortality of
diabetics, whereas only IHD obtained significance in the Cox
regression analysis. This may well be explained by the close
association between the HDL, VLDL and triglycerides, and
between these variables and IHD. The strong significance of
IHD besides UAE in the Cox regression analysis indicates that
even if an increased UAE rate reflects the vascular status of an
individual [26], IHD is an independent prognostic factor for
mortality.
We may therefore conclude that the urinary albumin excre-
tion rate predicts mortality in insulin dependent diabetics and
elderly non-diabetics, which is in contrast to the five to six year
mortality study, in which urinary albumin excretion rate had the
same strong predictive value in diabetics and non-diabetics.
After a longer observation period other factors, such as hyper-
tension and male sex, concur with the predictive value of UAE
in the non-diabetic population.
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